On Feb 05, 2026, DOCS reported earnings of 0.46 USD per share (EPS) for Q3 26, beating the estimate of 0.45 USD, resulting in a 1.21% surprise. Revenue reached 185.05 million, compared to an expected 185.85 million, with a -0.43% difference. The market reacted with a -16.78% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 23 analysts forecast an EPS of 0.28 USD, with revenue projected to reach 146.76 million USD, implying an decrease of -39.13% EPS, and decrease of -20.69% in Revenue from the last quarter.